The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Multi Cancer Early Detection Market Research Report 2025
Synopsis
Multi-cancer early detection (MCED) tests are tests that measure biological signals in body fluids that may be shed by cancer cells. These signals are also known as biomarkers or tumor markers. MCED tests are being developed to screen for cancers from more than one organ site at the same time.
The global Multi Cancer Early Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Multi Cancer Early Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Multi Cancer Early Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Multi Cancer Early Detection in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Multi Cancer Early Detection include Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc. and Singlera Genomics Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Multi Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi Cancer Early Detection.
Report Scope
The Multi Cancer Early Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multi Cancer Early Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi Cancer Early Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grail, LLC (Illumina, Inc.)
Exact Sciences Corporation.
Foundation Medicine, Inc.
AnchorDx
Guardant Health, Inc.
Burning Rock Biotech Limited
GENECAST
Laboratory for Advanced Medicine, Inc.
Singlera Genomics Inc.
Segment by Type
Liquid Biopsy
Gene Panel, LDT & Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi Cancer Early Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Multi-cancer early detection (MCED) tests are tests that measure biological signals in body fluids that may be shed by cancer cells. These signals are also known as biomarkers or tumor markers. MCED tests are being developed to screen for cancers from more than one organ site at the same time.
The global Multi Cancer Early Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Multi Cancer Early Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Multi Cancer Early Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Multi Cancer Early Detection in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Multi Cancer Early Detection include Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc. and Singlera Genomics Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Multi Cancer Early Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi Cancer Early Detection.
Report Scope
The Multi Cancer Early Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multi Cancer Early Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multi Cancer Early Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grail, LLC (Illumina, Inc.)
Exact Sciences Corporation.
Foundation Medicine, Inc.
AnchorDx
Guardant Health, Inc.
Burning Rock Biotech Limited
GENECAST
Laboratory for Advanced Medicine, Inc.
Singlera Genomics Inc.
Segment by Type
Liquid Biopsy
Gene Panel, LDT & Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multi Cancer Early Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multi Cancer Early Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid Biopsy
1.2.3 Gene Panel, LDT & Others
1.3 Market by Application
1.3.1 Global Multi Cancer Early Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multi Cancer Early Detection Market Perspective (2019-2030)
2.2 Multi Cancer Early Detection Growth Trends by Region
2.2.1 Global Multi Cancer Early Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Multi Cancer Early Detection Historic Market Size by Region (2019-2024)
2.2.3 Multi Cancer Early Detection Forecasted Market Size by Region (2025-2030)
2.3 Multi Cancer Early Detection Market Dynamics
2.3.1 Multi Cancer Early Detection Industry Trends
2.3.2 Multi Cancer Early Detection Market Drivers
2.3.3 Multi Cancer Early Detection Market Challenges
2.3.4 Multi Cancer Early Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multi Cancer Early Detection Players by Revenue
3.1.1 Global Top Multi Cancer Early Detection Players by Revenue (2019-2024)
3.1.2 Global Multi Cancer Early Detection Revenue Market Share by Players (2019-2024)
3.2 Global Multi Cancer Early Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multi Cancer Early Detection Revenue
3.4 Global Multi Cancer Early Detection Market Concentration Ratio
3.4.1 Global Multi Cancer Early Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multi Cancer Early Detection Revenue in 2023
3.5 Multi Cancer Early Detection Key Players Head office and Area Served
3.6 Key Players Multi Cancer Early Detection Product Solution and Service
3.7 Date of Enter into Multi Cancer Early Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multi Cancer Early Detection Breakdown Data by Type
4.1 Global Multi Cancer Early Detection Historic Market Size by Type (2019-2024)
4.2 Global Multi Cancer Early Detection Forecasted Market Size by Type (2025-2030)
5 Multi Cancer Early Detection Breakdown Data by Application
5.1 Global Multi Cancer Early Detection Historic Market Size by Application (2019-2024)
5.2 Global Multi Cancer Early Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Multi Cancer Early Detection Market Size (2019-2030)
6.2 North America Multi Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Multi Cancer Early Detection Market Size by Country (2019-2024)
6.4 North America Multi Cancer Early Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multi Cancer Early Detection Market Size (2019-2030)
7.2 Europe Multi Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Multi Cancer Early Detection Market Size by Country (2019-2024)
7.4 Europe Multi Cancer Early Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multi Cancer Early Detection Market Size (2019-2030)
8.2 Asia-Pacific Multi Cancer Early Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Multi Cancer Early Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific Multi Cancer Early Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multi Cancer Early Detection Market Size (2019-2030)
9.2 Latin America Multi Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Multi Cancer Early Detection Market Size by Country (2019-2024)
9.4 Latin America Multi Cancer Early Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multi Cancer Early Detection Market Size (2019-2030)
10.2 Middle East & Africa Multi Cancer Early Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Multi Cancer Early Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa Multi Cancer Early Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grail, LLC (Illumina, Inc.)
11.1.1 Grail, LLC (Illumina, Inc.) Company Detail
11.1.2 Grail, LLC (Illumina, Inc.) Business Overview
11.1.3 Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Introduction
11.1.4 Grail, LLC (Illumina, Inc.) Revenue in Multi Cancer Early Detection Business (2019-2024)
11.1.5 Grail, LLC (Illumina, Inc.) Recent Development
11.2 Exact Sciences Corporation.
11.2.1 Exact Sciences Corporation. Company Detail
11.2.2 Exact Sciences Corporation. Business Overview
11.2.3 Exact Sciences Corporation. Multi Cancer Early Detection Introduction
11.2.4 Exact Sciences Corporation. Revenue in Multi Cancer Early Detection Business (2019-2024)
11.2.5 Exact Sciences Corporation. Recent Development
11.3 Foundation Medicine, Inc.
11.3.1 Foundation Medicine, Inc. Company Detail
11.3.2 Foundation Medicine, Inc. Business Overview
11.3.3 Foundation Medicine, Inc. Multi Cancer Early Detection Introduction
11.3.4 Foundation Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2019-2024)
11.3.5 Foundation Medicine, Inc. Recent Development
11.4 AnchorDx
11.4.1 AnchorDx Company Detail
11.4.2 AnchorDx Business Overview
11.4.3 AnchorDx Multi Cancer Early Detection Introduction
11.4.4 AnchorDx Revenue in Multi Cancer Early Detection Business (2019-2024)
11.4.5 AnchorDx Recent Development
11.5 Guardant Health, Inc.
11.5.1 Guardant Health, Inc. Company Detail
11.5.2 Guardant Health, Inc. Business Overview
11.5.3 Guardant Health, Inc. Multi Cancer Early Detection Introduction
11.5.4 Guardant Health, Inc. Revenue in Multi Cancer Early Detection Business (2019-2024)
11.5.5 Guardant Health, Inc. Recent Development
11.6 Burning Rock Biotech Limited
11.6.1 Burning Rock Biotech Limited Company Detail
11.6.2 Burning Rock Biotech Limited Business Overview
11.6.3 Burning Rock Biotech Limited Multi Cancer Early Detection Introduction
11.6.4 Burning Rock Biotech Limited Revenue in Multi Cancer Early Detection Business (2019-2024)
11.6.5 Burning Rock Biotech Limited Recent Development
11.7 GENECAST
11.7.1 GENECAST Company Detail
11.7.2 GENECAST Business Overview
11.7.3 GENECAST Multi Cancer Early Detection Introduction
11.7.4 GENECAST Revenue in Multi Cancer Early Detection Business (2019-2024)
11.7.5 GENECAST Recent Development
11.8 Laboratory for Advanced Medicine, Inc.
11.8.1 Laboratory for Advanced Medicine, Inc. Company Detail
11.8.2 Laboratory for Advanced Medicine, Inc. Business Overview
11.8.3 Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Introduction
11.8.4 Laboratory for Advanced Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2019-2024)
11.8.5 Laboratory for Advanced Medicine, Inc. Recent Development
11.9 Singlera Genomics Inc.
11.9.1 Singlera Genomics Inc. Company Detail
11.9.2 Singlera Genomics Inc. Business Overview
11.9.3 Singlera Genomics Inc. Multi Cancer Early Detection Introduction
11.9.4 Singlera Genomics Inc. Revenue in Multi Cancer Early Detection Business (2019-2024)
11.9.5 Singlera Genomics Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Multi Cancer Early Detection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liquid Biopsy
Table 3. Key Players of Gene Panel, LDT & Others
Table 4. Global Multi Cancer Early Detection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Multi Cancer Early Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Multi Cancer Early Detection Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Multi Cancer Early Detection Market Share by Region (2019-2024)
Table 8. Global Multi Cancer Early Detection Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Multi Cancer Early Detection Market Share by Region (2025-2030)
Table 10. Multi Cancer Early Detection Market Trends
Table 11. Multi Cancer Early Detection Market Drivers
Table 12. Multi Cancer Early Detection Market Challenges
Table 13. Multi Cancer Early Detection Market Restraints
Table 14. Global Multi Cancer Early Detection Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Multi Cancer Early Detection Market Share by Players (2019-2024)
Table 16. Global Top Multi Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Early Detection as of 2023)
Table 17. Ranking of Global Top Multi Cancer Early Detection Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Multi Cancer Early Detection Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Multi Cancer Early Detection Product Solution and Service
Table 21. Date of Enter into Multi Cancer Early Detection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Multi Cancer Early Detection Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Multi Cancer Early Detection Revenue Market Share by Type (2019-2024)
Table 25. Global Multi Cancer Early Detection Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Multi Cancer Early Detection Revenue Market Share by Type (2025-2030)
Table 27. Global Multi Cancer Early Detection Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Multi Cancer Early Detection Revenue Market Share by Application (2019-2024)
Table 29. Global Multi Cancer Early Detection Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Multi Cancer Early Detection Revenue Market Share by Application (2025-2030)
Table 31. North America Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Multi Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Multi Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Multi Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Multi Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Multi Cancer Early Detection Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Multi Cancer Early Detection Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Multi Cancer Early Detection Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Multi Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Multi Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Multi Cancer Early Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Multi Cancer Early Detection Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Multi Cancer Early Detection Market Size by Country (2025-2030) & (US$ Million)
Table 46. Grail, LLC (Illumina, Inc.) Company Detail
Table 47. Grail, LLC (Illumina, Inc.) Business Overview
Table 48. Grail, LLC (Illumina, Inc.) Multi Cancer Early Detection Product
Table 49. Grail, LLC (Illumina, Inc.) Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 50. Grail, LLC (Illumina, Inc.) Recent Development
Table 51. Exact Sciences Corporation. Company Detail
Table 52. Exact Sciences Corporation. Business Overview
Table 53. Exact Sciences Corporation. Multi Cancer Early Detection Product
Table 54. Exact Sciences Corporation. Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 55. Exact Sciences Corporation. Recent Development
Table 56. Foundation Medicine, Inc. Company Detail
Table 57. Foundation Medicine, Inc. Business Overview
Table 58. Foundation Medicine, Inc. Multi Cancer Early Detection Product
Table 59. Foundation Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 60. Foundation Medicine, Inc. Recent Development
Table 61. AnchorDx Company Detail
Table 62. AnchorDx Business Overview
Table 63. AnchorDx Multi Cancer Early Detection Product
Table 64. AnchorDx Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 65. AnchorDx Recent Development
Table 66. Guardant Health, Inc. Company Detail
Table 67. Guardant Health, Inc. Business Overview
Table 68. Guardant Health, Inc. Multi Cancer Early Detection Product
Table 69. Guardant Health, Inc. Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 70. Guardant Health, Inc. Recent Development
Table 71. Burning Rock Biotech Limited Company Detail
Table 72. Burning Rock Biotech Limited Business Overview
Table 73. Burning Rock Biotech Limited Multi Cancer Early Detection Product
Table 74. Burning Rock Biotech Limited Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 75. Burning Rock Biotech Limited Recent Development
Table 76. GENECAST Company Detail
Table 77. GENECAST Business Overview
Table 78. GENECAST Multi Cancer Early Detection Product
Table 79. GENECAST Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 80. GENECAST Recent Development
Table 81. Laboratory for Advanced Medicine, Inc. Company Detail
Table 82. Laboratory for Advanced Medicine, Inc. Business Overview
Table 83. Laboratory for Advanced Medicine, Inc. Multi Cancer Early Detection Product
Table 84. Laboratory for Advanced Medicine, Inc. Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 85. Laboratory for Advanced Medicine, Inc. Recent Development
Table 86. Singlera Genomics Inc. Company Detail
Table 87. Singlera Genomics Inc. Business Overview
Table 88. Singlera Genomics Inc. Multi Cancer Early Detection Product
Table 89. Singlera Genomics Inc. Revenue in Multi Cancer Early Detection Business (2019-2024) & (US$ Million)
Table 90. Singlera Genomics Inc. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multi Cancer Early Detection Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Multi Cancer Early Detection Market Share by Type: 2023 VS 2030
Figure 3. Liquid Biopsy Features
Figure 4. Gene Panel, LDT & Others Features
Figure 5. Global Multi Cancer Early Detection Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Multi Cancer Early Detection Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Multi Cancer Early Detection Report Years Considered
Figure 11. Global Multi Cancer Early Detection Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Multi Cancer Early Detection Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Multi Cancer Early Detection Market Share by Region: 2023 VS 2030
Figure 14. Global Multi Cancer Early Detection Market Share by Players in 2023
Figure 15. Global Top Multi Cancer Early Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi Cancer Early Detection as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Multi Cancer Early Detection Revenue in 2023
Figure 17. North America Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Multi Cancer Early Detection Market Share by Country (2019-2030)
Figure 19. United States Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Multi Cancer Early Detection Market Share by Country (2019-2030)
Figure 23. Germany Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Multi Cancer Early Detection Market Share by Region (2019-2030)
Figure 31. China Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Multi Cancer Early Detection Market Share by Country (2019-2030)
Figure 39. Mexico Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Multi Cancer Early Detection Market Share by Country (2019-2030)
Figure 43. Turkey Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Multi Cancer Early Detection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Grail, LLC (Illumina, Inc.) Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 46. Exact Sciences Corporation. Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 47. Foundation Medicine, Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 48. AnchorDx Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 49. Guardant Health, Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 50. Burning Rock Biotech Limited Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 51. GENECAST Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 52. Laboratory for Advanced Medicine, Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 53. Singlera Genomics Inc. Revenue Growth Rate in Multi Cancer Early Detection Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
